Hims & Hers Health, Inc.
HIMS
$44.72
$0.7051.60%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 72.61% | 110.67% | 95.09% | 77.13% | 51.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 72.61% | 110.67% | 95.09% | 77.13% | 51.82% |
| Cost of Revenue | 117.90% | 216.49% | 162.21% | 112.41% | 56.37% |
| Gross Profit | 62.19% | 88.00% | 81.10% | 69.71% | 50.81% |
| SG&A Expenses | 54.95% | 67.50% | 71.89% | 49.47% | 35.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.11% | 96.39% | 87.93% | 61.18% | 40.26% |
| Operating Income | 141.42% | 494.28% | 762.96% | 361.56% | 219.85% |
| Income Before Tax | 144.73% | 387.74% | 915.07% | 441.14% | 287.22% |
| Income Tax Expenses | -7,700.00% | 763.53% | -492.64% | -8,086.94% | 1,076.92% |
| Earnings from Continuing Operations | 219.66% | 344.69% | 1,990.36% | 1,098.92% | 285.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 219.66% | 344.69% | 1,990.36% | 1,098.92% | 285.79% |
| EBIT | 141.42% | 494.28% | 762.96% | 361.56% | 219.85% |
| EBITDA | 152.77% | 420.63% | 442.97% | 532.19% | 314.49% |
| EPS Basic | 205.48% | 327.83% | 1,913.56% | 1,069.17% | 280.76% |
| Normalized Basic EPS | 133.42% | 377.53% | 387.01% | 430.58% | 282.33% |
| EPS Diluted | 198.06% | 313.81% | 1,830.36% | 993.33% | 265.01% |
| Normalized Diluted EPS | 123.46% | 361.47% | 363.95% | 404.37% | 266.51% |
| Average Basic Shares Outstanding | 4.55% | 4.00% | 3.52% | 3.08% | 2.97% |
| Average Diluted Shares Outstanding | 9.36% | 7.52% | 8.51% | 11.87% | 12.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |